Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

ResMed Inc announces change in status from executive to non-executive chairman


Tuesday, 7 Jan 2014 06:10pm EST 

ResMed Inc:Says effective as of Jan. 1, the board of directors of ResMed Inc. approved the appointment of Peter Farrell, its current executive chairman of the board of directors, as non-executive chairman of the board.Says as part of the transition, . Farrell will no longer be an executive officer of the company, although he will remain a non-officer employee. 

Company Quote

53.05
 --
25 Nov 2014